Elevra Lithium Ltd - Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing covers the month of June 2026 for Elevra Lithium Ltd (ASX: ELV, NASDAQ: ELVR), a North American hard-rock lithium producer. The filing summarizes Year-to-Date (YTD) Fiscal Year 2026 operational and financial performance, alongside strategic updates regarding asset expansion and financing.
Key Financial and Operational Metrics
- Revenue: US$167 million (YTD FY26).
- Production: 143,489 dry metric tonnes (dmt) produced YTD FY26.
- Sales: 147,517 dmt sold YTD FY26.
- Unit Operating Cost: US$840 per dmt (YTD FY26).
- Recovery Rate: 66%.
- Operating Cash Flow: US$41 million generated by the North American Lithium (NAL) asset in Q3 FY26.
- Liquidity (Pro-Forma): US$1,887 million net cash following strategic financing announced May 12, 2026.
- Market Capitalization (Pro-Forma): US$321 million.
- Shares Outstanding (Pro-Forma): 193 million.
Material Changes and Operational Highlights
- Production Efficiency: Q3 FY26 concentrate production reached a record 47kt, driven by improved plant utilization and process modifications.
- Cost Dynamics: Higher realized sales prices were partially offset by higher unit operating costs in Q3 FY26.
- Resource Base: Ore uncovered increased 25% quarter-over-quarter, improving feed consistency. Lithium recovery improved to 66% due to ore sorting efforts.
- Capital Structure: Significant pro-forma changes reflect a strategic financing package announced on May 12, 2026, resulting in US$1,887 million in net cash.
Guidance, Outlook, and Strategic Initiatives
- NAL Expansion: An updated scoping study confirms a staged expansion plan for the North American Lithium (NAL) asset. The plan targets a +45% increase in average annual production capacity and a 21% reduction in C1 costs over the long term.
- Expansion Timeline: Stage 1 (Mill Optimisation) targets completion by mid-CY27. Stage 2 (Mill Expansion) and Stage 3 (Full Production) are targeted for CY29 and CY28 respectively.
- Offtake Agreements: Elevra signed a non-binding Memorandum of Understanding (MoU) with Mangrove Lithium to supply spodumene concentrate from NAL.
- Growth Portfolio:
- Moblan (60% owned): Fully funded for pre-development activities; resource base increased 6.5x since acquisition to 121Mt @ 1.19% Li2O.
- Carolina Lithium (100% owned): Brownfield expansion scoping study completed with strong economics.
- Risks and Contingencies: The filing includes standard forward-looking statement disclaimers. Mineral resource estimates for NAL, Authier, and Moblan are reported under JORC/NI 43-101 standards and are not directly comparable to US S-K 1300 standards.
Investor Verification Checklist
- Verify the final terms and closing of the strategic financing package announced May 12, 2026, to confirm the pro-forma net cash position of US$1,887 million.
- Review the binding status of the offtake agreement with Mangrove Lithium, currently noted as a non-binding MoU.
- Monitor the execution timeline for the NAL Stage 1 expansion (targeted mid-CY27) and associated capital expenditure of US$71 million.
- Confirm the reconciliation of mineral resource estimates between JORC/NI 43-101 standards and US S-K 1300 requirements for US investors.
- Track the progress of Moblan permitting and the Definitive Feasibility Study (DFS) update incorporating the expanded resource base.